{"schema_version":"secwatch.filing_event.v1","accession":"0001055726-24-000053","form_type":"8-K","ticker":"INO","cik":"0001055726","company_name":"INOVIO PHARMACEUTICALS, INC.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.518127+00:00","generated_at":"2026-05-30T00:12:20.002566+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Inovio Q3 net loss $25.2M; INO-3107 BLA on track for mid-2025 submission","bullets":["Net loss of $25.2M ($0.89/share) vs $33.9M loss in Q3 2023; R&D expense $18.7M, G&A $8.6M.","Cash, equivalents and short-term investments $84.8M at Sept 30, 2024; cash runway into Q3 2025.","INO-3107 Phase 1/2 data: 81% of 32 patients had fewer surgeries; 28% had zero surgeries post-treatment.","All non-device BLA modules for INO-3107 on track for completion by year-end 2024; BLA submission targeted mid-2025.","Advancing Phase 3 plan for INO-3112 in HPV+ throat cancer; Phase 2 Ebola vaccine booster trial in FDA discussions."],"urls":{"canonical":"https://secwatch.observer/filing/0001055726-24-000053","json":"https://secwatch.observer/filing/0001055726-24-000053.json","markdown":"https://secwatch.observer/filing/0001055726-24-000053.md","text":"https://secwatch.observer/filing/0001055726-24-000053.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000053/0001055726-24-000053-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1055726/000105572624000053/ino-20241114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:12:20.002566+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}